Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern

J Hypertens. 2024 Jun 1;42(6):966-967. doi: 10.1097/HJH.0000000000003735. Epub 2024 May 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists* / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Humans
  • Hypertension* / drug therapy

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents